Acta Scientific Pharmaceutical Sciences (ASPS)(ISSN: 2581-5423)

Short Communication Volume 4 Issue 3

Cancer: A Translational Biology Disease

Daniel Gandia*

Department of Cancer Medicine and IQVIA, Buenos Aires, Argentina

*Corresponding Author: Daniel Gandia, Department of Cancer Medicine and IQVIA, Buenos Aires, Argentina.

Received: December 24, 2019; Published: January 11, 2020


  Cancer is not only one of the most fascinating cellular diseases, but also the one more threatening one. Its incidence and prevalence are continuously rising, mainly due to DNA- damaging xenobiotics.

   Cancer Prevention is a goal of maximal priority, and early detection and treatment a current reality for some of the frequent malignancies mainly geographically- related (Cervical Cancer prevalence in underdeveloped countries).





Citation: Daniel Gandia. “Cancer: A Translational Biology Disease" Acta Scientific Pharmaceutical Sciences 4.3 (2020): 01.

Member In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 15, 2020.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US